Human pancreatic adenocarcinoma contains a side population resistant to gemcitabine Full Text
BMC Cancer, 08/16/2012
Van den broeck A et al. – The authors identified a side population (SP) in human pancreatic ductal adenocarcinoma (PDAC) and uncovered a chemoresistant and cancer stem cell (CSC)–associated phenotype. This SP may represent a new therapeutic target in pancreatic cancer.